Skip to main content
Top
Published in: Inflammation 3/2012

01-06-2012

The Anti-inflammatory Mechanism of Heme Oxygenase-1 Induced by Hemin in Primary Rat Alveolar Macrophages

Authors: Chen Hualin, Xu Wenli, Liu Dapeng, Li Xijing, Pan Xiuhua, Pang Qingfeng

Published in: Inflammation | Issue 3/2012

Login to get access

Abstract

Alveolar macrophages (AMs) can initiate lung inflammation by producing pro-inflammatory cytokines and chemokines, but they participate actively in the prevention of inflammation during acute lung injury (ALI). Heme oxygenase-1 (HO-1) is mainly expressed in AMs and has anti-inflammatory properties in ALI, but the anti-inflammatory mechanisms of HO-1 are largely unknown. In this study, AMs were treated with saline, LPS (1 μg/ml), hemin (10 μM), zinc protoporphyrin (ZnPP; 10 μM, 1 h prior to LPS and hemin), SB203580 (10 μM, 1 h prior to LPS and hemin), or their combination up to 24 h. The specific HO-1 inhibitor ZnPP and SB203580 were used to inhibit the effects of HO-1 and the phosphorylated p38 mitogen-activated protein kinase (MAPK), respectively. The protein levels of HO-1 and p38 MAPK were analyzed by western blotting; arginase activity was measured in lysates obtained from cultured cells; nitric oxide production in the extracellular medium of AMs cultured for 24 h was monitored by assessing nitrite levels; the phagocytic ability of macrophage was measured by neutral red uptake. IL-10 of culture supernatants in AMs was determined by enzyme-linked immunosorbent assay. The results indicated that HO-1 induced by hemin increased arginase activity and phagocytic ability and decreased iNOS activity via p38 MAPK pathway in primary rat AMs. These changes and p38 MAPK may be the anti-inflammatory mechanism of HO-1 induced by hemin in primary rat AMs.
Literature
1.
go back to reference Zhao, M., L.G. Fernandez, A. Doctor, A.K. Sharma, A. Zarbock, and C.G. Tribble. 2006. Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 291: L1018–L1026.PubMedCrossRef Zhao, M., L.G. Fernandez, A. Doctor, A.K. Sharma, A. Zarbock, and C.G. Tribble. 2006. Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 291: L1018–L1026.PubMedCrossRef
2.
go back to reference Matute, B.G., and T.R. Martin. 2003. Science review: apoptosis in acute lung injury. Critical Care 7: 355–358.CrossRef Matute, B.G., and T.R. Martin. 2003. Science review: apoptosis in acute lung injury. Critical Care 7: 355–358.CrossRef
3.
go back to reference Miyake, Y., H. Kaise, K. Isono, H. Koseki, K. Kohno, and M. Tanaka. 2007. Protective role of macrophages in noninflammatory lung injury caused by selective ablation of alveolar epithelial type II cells. Journal of Immunology 178: 5001–5009. Miyake, Y., H. Kaise, K. Isono, H. Koseki, K. Kohno, and M. Tanaka. 2007. Protective role of macrophages in noninflammatory lung injury caused by selective ablation of alveolar epithelial type II cells. Journal of Immunology 178: 5001–5009.
4.
go back to reference Pang, Q.F., Q.M. Zhou, S. Zeng, L.D. Dou, J. Yong, and Y.M. Zeng. 2008. Protective effect of heme oxygenase-1 on lung injury induced by erythrocyte instillation in rats. Chinese Medical Journal 121: 1688–1692.PubMed Pang, Q.F., Q.M. Zhou, S. Zeng, L.D. Dou, J. Yong, and Y.M. Zeng. 2008. Protective effect of heme oxygenase-1 on lung injury induced by erythrocyte instillation in rats. Chinese Medical Journal 121: 1688–1692.PubMed
5.
go back to reference Deshane, J., M. Wright, and A. Agarwal. 2005. Heme oxygenase-1 expression in disease states. Acta Biochimica 52: 273–284. Deshane, J., M. Wright, and A. Agarwal. 2005. Heme oxygenase-1 expression in disease states. Acta Biochimica 52: 273–284.
6.
go back to reference Kirkby, K.A., and C.A. Adin. 2006. Products of heme oxygenase and their potential therapeutic applications. American Journal of Physiology. Renal Physiology 290: F563–F571.PubMedCrossRef Kirkby, K.A., and C.A. Adin. 2006. Products of heme oxygenase and their potential therapeutic applications. American Journal of Physiology. Renal Physiology 290: F563–F571.PubMedCrossRef
7.
go back to reference Takaki, S., N. Takeyama, Y. Kajita, T. Yabuki, H. Noguchi, and Y. Miki. 2010. Beneficial effects of the heme oxygenase-1/carbon monoxide system in patients with severe sepsis/septic shock. Intensive Care Medicine 36: 42–48.PubMedCrossRef Takaki, S., N. Takeyama, Y. Kajita, T. Yabuki, H. Noguchi, and Y. Miki. 2010. Beneficial effects of the heme oxygenase-1/carbon monoxide system in patients with severe sepsis/septic shock. Intensive Care Medicine 36: 42–48.PubMedCrossRef
8.
go back to reference Morse, D., L. Lin, A.M. Choi, and S.W. Ryter. 2009. Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease. Free Radical Biology & Medicine 47: 1–12.CrossRef Morse, D., L. Lin, A.M. Choi, and S.W. Ryter. 2009. Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease. Free Radical Biology & Medicine 47: 1–12.CrossRef
9.
go back to reference McCourtie, A.S., H.E. Merry, A.S. Farivar, C.H. Goss, and M.S. Mulligan. 2008. Alveolar macrophage secretory products augment the response of rat pulmonary artery endothelial cells to hypoxia and reoxygenation. The Annals of Thoracic Surgery 85: 1056–1060.PubMedCrossRef McCourtie, A.S., H.E. Merry, A.S. Farivar, C.H. Goss, and M.S. Mulligan. 2008. Alveolar macrophage secretory products augment the response of rat pulmonary artery endothelial cells to hypoxia and reoxygenation. The Annals of Thoracic Surgery 85: 1056–1060.PubMedCrossRef
10.
go back to reference Meyer, M., F. Huaux, X. Gavilanes, S. van den Brûle, P. Lebecque, S. Lo Re, and D. Lison. 2009. Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis. American Journal of Respiratory Cell and Molecular Biology 41: 590–602.PubMedCrossRef Meyer, M., F. Huaux, X. Gavilanes, S. van den Brûle, P. Lebecque, S. Lo Re, and D. Lison. 2009. Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis. American Journal of Respiratory Cell and Molecular Biology 41: 590–602.PubMedCrossRef
11.
go back to reference Chen, W., W. Zhang, W. Shen, and K. Wang. 2010. Effects of the acid polysaccharide fraction isolated from a cultivated Cordyceps sinensis on macrophages in vitro. Cellular Immunology 262: 69–74.PubMedCrossRef Chen, W., W. Zhang, W. Shen, and K. Wang. 2010. Effects of the acid polysaccharide fraction isolated from a cultivated Cordyceps sinensis on macrophages in vitro. Cellular Immunology 262: 69–74.PubMedCrossRef
12.
go back to reference Otterbein, L.E., and A.M. Choi. 2000. Heme oxygenase: colors of defense against cellular stress. American Journal of Physiology 270: L1029–L1037. Otterbein, L.E., and A.M. Choi. 2000. Heme oxygenase: colors of defense against cellular stress. American Journal of Physiology 270: L1029–L1037.
13.
go back to reference Otterbein, L.E., M.P. Soares, K. Yamashita, and F.H. Bach. 2003. Heme oxygenase-1: unleashing the protective properties of heme. Trends in Immunology 24: 449–455.PubMedCrossRef Otterbein, L.E., M.P. Soares, K. Yamashita, and F.H. Bach. 2003. Heme oxygenase-1: unleashing the protective properties of heme. Trends in Immunology 24: 449–455.PubMedCrossRef
14.
go back to reference Kim, H.P., S.W. Ryter, and A.M. Choi. 2006. Co as a cellular signaling molecule. Annual Review of Pharmacology and Toxicology 46: 411–449.PubMedCrossRef Kim, H.P., S.W. Ryter, and A.M. Choi. 2006. Co as a cellular signaling molecule. Annual Review of Pharmacology and Toxicology 46: 411–449.PubMedCrossRef
15.
go back to reference Carraway, M.S., A.J. Ghio, J.D. Carter, and C.A. Piantadosi. 2000. Expression of heme oxygenase-1 in the lung in chronic hypoxia. American Journal of Respiratory Cell and Molecular Biology 278: L806–L812. Carraway, M.S., A.J. Ghio, J.D. Carter, and C.A. Piantadosi. 2000. Expression of heme oxygenase-1 in the lung in chronic hypoxia. American Journal of Respiratory Cell and Molecular Biology 278: L806–L812.
16.
go back to reference Carraway, M.S., A.J. Ghio, J.L. Taylor, and C.A. Piantadosi. 1998. Induction of ferritin and heme oxygenase-1 by endotoxin in the lung. American Journal of Lung Cellular and Molecular Physiology 275: L583–L592. Carraway, M.S., A.J. Ghio, J.L. Taylor, and C.A. Piantadosi. 1998. Induction of ferritin and heme oxygenase-1 by endotoxin in the lung. American Journal of Lung Cellular and Molecular Physiology 275: L583–L592.
17.
go back to reference Eyssen-Hernandez, R., A. Ladoux, and C. Frelin. 1996. Differential regulation of cardiac heme oxygenase-1 and vascular endothelial growth factor mRNA expressions by hemin, heavy metals, heat shock and anoxia. FEBS Letters 382: 229–233.PubMedCrossRef Eyssen-Hernandez, R., A. Ladoux, and C. Frelin. 1996. Differential regulation of cardiac heme oxygenase-1 and vascular endothelial growth factor mRNA expressions by hemin, heavy metals, heat shock and anoxia. FEBS Letters 382: 229–233.PubMedCrossRef
18.
go back to reference Ferrándiz, M.L., and I. Devesa. 2008. Inducers of heme oxygenase-1. Current Pharmaceutical Design 14: 473–486.PubMedCrossRef Ferrándiz, M.L., and I. Devesa. 2008. Inducers of heme oxygenase-1. Current Pharmaceutical Design 14: 473–486.PubMedCrossRef
19.
go back to reference Ashino, T., R. Yamanaka, M. Yamamoto, H. Shimokawa, K. Sekikawa, and Y. Iwakura. 2008. Negative feedback regulation of lipopolysaccharide-induced inducible nitric oxide synthase gene expression by heme oxygenase-1 induction in macrophages. Molecular Immunology 45: 2106–2115.PubMedCrossRef Ashino, T., R. Yamanaka, M. Yamamoto, H. Shimokawa, K. Sekikawa, and Y. Iwakura. 2008. Negative feedback regulation of lipopolysaccharide-induced inducible nitric oxide synthase gene expression by heme oxygenase-1 induction in macrophages. Molecular Immunology 45: 2106–2115.PubMedCrossRef
20.
go back to reference Lin, H.Y., S.H. Juan, S.C. Shen, F.L. Hsu, and Y.C. Chen. 2003. Inhibition of lipopolysaccharide induced nitric oxide production by flavonoids in RAW264.7 macrophages involves heme oxygenase-1. Biochemical Pharmacology 66: 1821–1832.PubMedCrossRef Lin, H.Y., S.H. Juan, S.C. Shen, F.L. Hsu, and Y.C. Chen. 2003. Inhibition of lipopolysaccharide induced nitric oxide production by flavonoids in RAW264.7 macrophages involves heme oxygenase-1. Biochemical Pharmacology 66: 1821–1832.PubMedCrossRef
21.
go back to reference Lin, H.Y., S.C. Shen, and Y.C. Chen. 2005. Anti-inflammatory effect of heme oxygenase 1: glycosylation and nitric oxide inhibition in macrophages. Journal of Cellular Physiology 202: 579–590.PubMedCrossRef Lin, H.Y., S.C. Shen, and Y.C. Chen. 2005. Anti-inflammatory effect of heme oxygenase 1: glycosylation and nitric oxide inhibition in macrophages. Journal of Cellular Physiology 202: 579–590.PubMedCrossRef
22.
go back to reference Maestrelli, P., C. Páska, M. Saetta, G. Turato, Y. Nowicki, and S. Monti. 2003. Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients. European Respiratory Journal 21: 971–976.PubMedCrossRef Maestrelli, P., C. Páska, M. Saetta, G. Turato, Y. Nowicki, and S. Monti. 2003. Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients. European Respiratory Journal 21: 971–976.PubMedCrossRef
23.
go back to reference Wang, W.W., C.P. Jenkinson, J.M. Griscavage, R.M. Kern, N.S. Arabolos, and R.E. Byrns. 1995. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochemical and Biophysical Research Communications 210: 1009–1016.PubMedCrossRef Wang, W.W., C.P. Jenkinson, J.M. Griscavage, R.M. Kern, N.S. Arabolos, and R.E. Byrns. 1995. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochemical and Biophysical Research Communications 210: 1009–1016.PubMedCrossRef
24.
go back to reference Meurs, H., H. Maarsingh, and J. Zaagsma. 2003. Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends in Pharmacological Sciences 24: 450–455.PubMedCrossRef Meurs, H., H. Maarsingh, and J. Zaagsma. 2003. Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends in Pharmacological Sciences 24: 450–455.PubMedCrossRef
25.
go back to reference Zhai, Z., A. Solco, L. Wu, E.S. Wurtele, M.L. Kohut, P.A. Murphy, and J.E. Cunnick. 2009. Echinacea increases arginase activity and has anti-inflammatory properties in RAW 264.7 macrophage cells, indicative of alternative macrophage activation. Journal of Ethnopharmacology 122: 76–85.PubMedCrossRef Zhai, Z., A. Solco, L. Wu, E.S. Wurtele, M.L. Kohut, P.A. Murphy, and J.E. Cunnick. 2009. Echinacea increases arginase activity and has anti-inflammatory properties in RAW 264.7 macrophage cells, indicative of alternative macrophage activation. Journal of Ethnopharmacology 122: 76–85.PubMedCrossRef
26.
go back to reference Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends in Immunology 23: 549–555.PubMedCrossRef Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends in Immunology 23: 549–555.PubMedCrossRef
27.
go back to reference Gratchev, A., J. Kzhyshkowska, J. Utikal, and S. Goerdt. 2005. Interleukin-4 and dexamethasone counterregulate extracellular matrix remodelling and phagocytosis in type-2 macrophages. Scandinavian Journal of Immunology 61: 10–17.PubMedCrossRef Gratchev, A., J. Kzhyshkowska, J. Utikal, and S. Goerdt. 2005. Interleukin-4 and dexamethasone counterregulate extracellular matrix remodelling and phagocytosis in type-2 macrophages. Scandinavian Journal of Immunology 61: 10–17.PubMedCrossRef
28.
go back to reference Lee, J.C., J.T. Laydon, and P.C. McDonnell. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739–746.PubMedCrossRef Lee, J.C., J.T. Laydon, and P.C. McDonnell. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739–746.PubMedCrossRef
29.
go back to reference Han, J., J.D. Lee, L. Bibbs, and R.J. Ulevitch. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808–811.PubMedCrossRef Han, J., J.D. Lee, L. Bibbs, and R.J. Ulevitch. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808–811.PubMedCrossRef
30.
go back to reference Yong, H.Y., M.S. Koh, and A. Moon. 2009. The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer. Expert Opinion Investigation 18: 1893–1905.CrossRef Yong, H.Y., M.S. Koh, and A. Moon. 2009. The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer. Expert Opinion Investigation 18: 1893–1905.CrossRef
31.
go back to reference Chanteux, H., A.C. Guisset, C. Pilette, and Y. Sibille. 2002. LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanisms. Respiratory Research 8: 71.CrossRef Chanteux, H., A.C. Guisset, C. Pilette, and Y. Sibille. 2002. LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanisms. Respiratory Research 8: 71.CrossRef
32.
go back to reference Schwacha, M.G., I.H. Chaudey, and M. Alexander. 2003. Regulation of macrophage IL-10 production postinjury via beta2 integrin signaling and the P38 MAP kinase pathway. Shock 20: 529–535.PubMedCrossRef Schwacha, M.G., I.H. Chaudey, and M. Alexander. 2003. Regulation of macrophage IL-10 production postinjury via beta2 integrin signaling and the P38 MAP kinase pathway. Shock 20: 529–535.PubMedCrossRef
33.
go back to reference Seimon, T.A., Y. Wang, S. Han, and T. Senokuchi. 2009. Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice. The Journal of Clinical Investigation 119: 886–898.PubMed Seimon, T.A., Y. Wang, S. Han, and T. Senokuchi. 2009. Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice. The Journal of Clinical Investigation 119: 886–898.PubMed
34.
go back to reference Li, Y.Z., Y.X. Zhong, X. Fang, and C.C. Bang. 2008. Effect of radix paeoniae rubra on expression of p38 MAPK/iNOS/HO-1 in rats with lipopolysaccharide-induced acute lung injury. Chinese Medical Journal 121: 1688–1692. Li, Y.Z., Y.X. Zhong, X. Fang, and C.C. Bang. 2008. Effect of radix paeoniae rubra on expression of p38 MAPK/iNOS/HO-1 in rats with lipopolysaccharide-induced acute lung injury. Chinese Medical Journal 121: 1688–1692.
35.
go back to reference Wang, X.M., H.P. Kim, K. Nakahira, S.W. Ryter, and A.M. Choi. 2009. The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. Journal of Immunology 182: 3809–3818.CrossRef Wang, X.M., H.P. Kim, K. Nakahira, S.W. Ryter, and A.M. Choi. 2009. The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. Journal of Immunology 182: 3809–3818.CrossRef
36.
go back to reference Williams, J.A., C.H. Pontzer, and E. Shacter. 2000. Regulation of macrophage interleukin-6 (IL-6) and IL-10 expression by prostaglandin E2: the role of p38 mitogen-activated protein kinase. Journal of Interferon and Cytokine Research 20: 291–298.PubMedCrossRef Williams, J.A., C.H. Pontzer, and E. Shacter. 2000. Regulation of macrophage interleukin-6 (IL-6) and IL-10 expression by prostaglandin E2: the role of p38 mitogen-activated protein kinase. Journal of Interferon and Cytokine Research 20: 291–298.PubMedCrossRef
37.
go back to reference Ricchetti, G.A., L.M. Williams, and B.M. Foxwell. 2004. Heme oxygenase 1 expression induced by IL-10 requires STAT-3 and phosphoinositol-3 kinase and is inhibited by lipopolysaccharide. Journal of Leukocyte Biology 76: 719–726.PubMedCrossRef Ricchetti, G.A., L.M. Williams, and B.M. Foxwell. 2004. Heme oxygenase 1 expression induced by IL-10 requires STAT-3 and phosphoinositol-3 kinase and is inhibited by lipopolysaccharide. Journal of Leukocyte Biology 76: 719–726.PubMedCrossRef
38.
go back to reference Lee, T.S., and L.Y. Chau. 2002. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nature Medicine 8: 240–246.PubMedCrossRef Lee, T.S., and L.Y. Chau. 2002. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nature Medicine 8: 240–246.PubMedCrossRef
Metadata
Title
The Anti-inflammatory Mechanism of Heme Oxygenase-1 Induced by Hemin in Primary Rat Alveolar Macrophages
Authors
Chen Hualin
Xu Wenli
Liu Dapeng
Li Xijing
Pan Xiuhua
Pang Qingfeng
Publication date
01-06-2012
Publisher
Springer US
Published in
Inflammation / Issue 3/2012
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-011-9415-4

Other articles of this Issue 3/2012

Inflammation 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.